Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Bohai Pharmaceuticals Group, Inc. | v235937_10k.htm |
| EX-31.1 - EXHIBIT 31.1 - Bohai Pharmaceuticals Group, Inc. | v235937_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - Bohai Pharmaceuticals Group, Inc. | v235937_ex31-2.htm |
| EX-32.1 - EXHIBIT 32.1 - Bohai Pharmaceuticals Group, Inc. | v235937_ex32-1.htm |
| EX-32.2 - EXHIBIT 32.2 - Bohai Pharmaceuticals Group, Inc. | v235937_ex32-2.htm |
Exhibit 21.1
Subsidiaries of the Registrant
|
1.
|
The Company’s wholly owned subsidiary, Chance High International Limited, a British Virgin Islands company (“Chance High”);
|
|
2.
|
Chance High’s wholly owned subsidiary, Yantai Shencaojishi Pharmaceuticals Co., Ltd., a PRC company (“WFOE”);
|
|
3.
|
Chance High’s wholly owned subsidiary, Yantai Nirui Pharmaceutical Co., Ltd., a PRC company (“WFOE II”);
|
|
4.
|
the WFOE’s variable interest entity, Yantai Bohai Pharmaceuticals Group Co., Ltd., a PRC company (“Bohai”), which is the Company’s initial operating subsidiary; and
|
|
5.
|
WFOE II’s wholly owned subsidiary, Yantai Tianzheng Pharmaceutical Co., Ltd., a PRC company (“Yantai Tianzheng”), which the Company acquired in August 2011 and is the Company’s second operating subsidiary.
|